Working Toward a Cure

Research Excellence
Katie Politi

Mutations in the Epidermal Growth Factor Receptor (EGFR) are found in 10-20% of lung adenocarcinomas. These mutations are most common in tumors in never-smokers and are associated with sensitivity to drugs... Read more...  

Research Excellence

Awards and Honors

Ruslan Medzhitov, PhD, a member of the Yale Cancer Center Cancer Immunology Program, is one of three scientists awarded the prestigious Shaw Prize in Life Science and Medicine for 2011.  Read More...

Working Toward a Cure

Research Excellence
Frank Slack

Development is a four-dimensional process, explicitly controlled by genes, that begins with fertilization and ends with death. We are using the advantages of the model organism C. elegans to find important genes and mechanisms that control developmental timing. Read More...  

Research Excellence

Awards and Honors

Meena Moran, MD has recently been nominated to join the editorial board of the Journal of Clinical Oncology (JCO). Dr. Moran is an Associate Professor of Therapeutic Radiology and a member of the Yale Cancer Center Radiobiology & Radiotherapy Research Program.  

Research Excellence

Awards and Honors

Anthony Koleske, PhD and Titus Boggon, PhD, both members of the Yale Cancer Center Signal Transduction Program, are the recipients of a 2011 Women's Health Research at Yale Pilot Grant, co-funded by Yale Cancer Center.  

Working Toward a Cure

Research Excellence
David Stern

The HER-2/Neu/ErbB-2 receptor tyrosine kinase is a major human oncogene and a validated therapeutic target in breast cancer. We are investigating the normal and carcinogenic functions of HER2 and other EGF receptor family kinases to understand how they cause cancers. Read More...  

Working Toward a Cure

In the fight against cancer, Yale has been at the forefront of understanding the fundamental mechanisms of cancer biology and in developing effective therapies for the treatment of cancer.  

Working Toward a Cure

Yale Cancer Center harnesses the resources of the Yale School of Medicine and Smilow Cancer Hospital at Yale-New Haven to advance cancer research, prevention, and patient care, as well as community outreach and education.